[Influence of maggot excretions/secretions on the anti- Pseudomonas aeruginosa effect of neutrophils in patients with diabetic foot ulcer]
Goal: To analyze the results of medical maggots excretions/secretions (ES) on neutrophils phagocytosis and bactericidal impact in sufferers with diabetic foot ulcer (DFU).
Strategies: The experimental analysis methodology was used. Thirty DFU sufferers [16 males and 14 females, aged (64±7) years] who have been admitted to the Diabetes Foot Heart, the Division of Endocrinology of Air Power Hospital of Japanese Theater Command from June 2020 to December 2020 and met the inclusion standards have been recruited.
Discontinuous percoll gradient centrifugation methodology was used to separate the neutrophils. Cells from every affected person have been recruited in regular saline group and maggot ES group (30 wells in every group), respectively; sterile regular saline and ES with a remaining mass focus of 400 μg/mL (the identical as under) have been added, respectively. After 1, 2 hour(s) of tradition, the phagocytosis fee and phagocytic index of cells have been noticed and counted beneath Wright’s staining.
Ten sufferers have been chosen, then the cells of every affected person have been recruited in Pseudomonas aeruginosa+neutrophils group, and Pseudomonas aeruginosa+neutrophils+maggot ES group (10 wells in every group) as earlier than. Pseudomonas aeruginosa+neutrophils+sterile regular saline, Pseudomonas aeruginosa+neutrophils+maggot ES have been added, respectively. Pseudomonas aeruginosa alone group and Pseudomonas aeruginosa+maggot ES group (10 wells in every group) have been arrange respectively; Pseudomonas aeruginosa+RPMI 1640 tradition medium+sterile regular saline, Pseudomonas aeruginosa+RPMI 1640 tradition medium+maggot ES have been added, respectively.
After 2 hours of tradition, the variety of viable micro organism colonies was counted by plate colony quantity methodology. Six, six, and three sufferers have been chosen, and the cells of every affected person have been respectively recruited in maggot ES group and regular saline group (6, 6, and three wells in every group, respectively) and handled accordingly as earlier than.
After 6 hours of tradition, real-time fluorescent quantitative reverse transcription polymerase chain response have been used to detect the mRNA expressions of interleukin 1β (IL-1β), IL-6, and lysozyme in cells, the content material of IL-1β and IL-6 in cell tradition supernatant have been decided by enzyme-linked immunosorbent assay,
the optimistic cells expressing lysozyme have been noticed with immunofluorescence methodology. Information have been statistically analyzed with one-way evaluation of variance, paired pattern t check, least vital distinction check, and Wilcoxon rank sum check.
Outcomes: After 1 hour of tradition, the phagocytosis fee and phagocytic index of cells in maggot ES group [53.5% (49.7%, 58.0%) and 3.18 (2.96, 3.32)] have been just like 52.0% (47.5%, 55.2%) and three.15 (2.96, 3.25) of regular saline group (Z=-1.701, -1.092, P>0.05).
After 2 hours of tradition, the phagocytosis fee and phagocytic index of cells in maggot ES group [70.0% (66.7%, 72.0%) and 4.47 (4.22, 4.96)] have been considerably greater than 58.0% (55.0%, 60.0%) and 4.11 (3.52, 4.24) in regular saline group (Z=-4.786, -4.279, P<0.01). After 2 hours of tradition, the variety of viable micro organism colonies in Pseudomonas aeruginosa+neutrophils group was considerably decrease than that in Pseudomonas aeruginosa alone group (P<0.01), and the variety of viable micro organism colonies in Pseudomonas aeruginosa+neutrophils+maggot ES group was considerably decrease than that in Pseudomonas aeruginosa+maggot ES group and Pseudomonas aeruginosa+neutrophils group (P<0.01); the mRNA expressions of IL-1β, IL-6, and lysozyme in maggot ES group have been considerably greater these in regular saline group (t=-3.279, -4.273, -4.763, P<0.05 or P<0.01);
the concent of IL-1β and IL-6 in cell tradition supernatant of maggot ES group have been considerably greater than these of regular saline group (t=-9.526, -6.447, P<0.01); lysozyme optimistic cells in maggot ES group have been considerably greater than these in regular saline group.
Conclusions: Maggot ES can improve the phagocytosis and bactericidal impact of neutrophils on Pseudomonas aeruginosa in DFU sufferers.
Description: Non-RI dependent diabetes, or Type 2 Diabetes, is characterized by hyperglycemia that is caused by a combination of RI resistance and the body's inability to compensate by producing more RI.
Description: Non-RI dependent diabetes, or Type 2 Diabetes, is characterized by hyperglycemia that is caused by a combination of RI resistance and the body's s inability to compensate by producing more RI.
Description: Type I Diabetes peripheral blood plasma is obtained by centrifugation of the Type I Diabetes PB. This product has a diminished number of cells and platelets. Fresh Diabetic Type I PB plasma is available upon request.
Description: Type II Diabetes peripheral blood plasma is obtained by centrifugation of the Type II Diabetes PB. This product has a diminished number of cells and platelets. Fresh Diabetic Type II PB plasma is available upon request.
Description: Diabetic Type I and Type II HSMM-Human Skeletal Muscle Myoblasts are isolated from donors diagnosed with either Diabetes Type I or Diabetes Type II. Additional donor information is available by contacting Scientific Support.
Description: Diabetic Type I and Type II HSMM-Human Skeletal Muscle Myoblasts are isolated from donors diagnosed with either Diabetes Type I or Diabetes Type II. Additional donor information is available by contacting Scientific Support.
Description: Induced Pluriopotent Stem Cells (iPSCs) are a type of pluripotent stem cells that can be derived directly from adult somatic cells . The derived iPSCs can propagate indefinitely, as well as give rise to other cell types in the body. iPS cells, thus, hold great promise in the field of regenerative medicine by representing a single source of cells that could be used to replace those damaged/diseased cells.
The TELE-DD mission on therapy nonadherence within the inhabitants with sort 2 diabetes and comorbid despair
Diabetic sufferers have elevated despair charges, diminished high quality of life, and better demise charges attributable to despair comorbidity or diabetes issues. Remedy adherence (TA) and the upkeep of an enough and competent self-care are essential components to achieve optimum glycaemic management and secure high quality of life in these sufferers.
On this report, we current the baseline inhabitants analyses in part I of the TELE-DD mission, a three-phased population-based examine in 23 Well being Centres from the Aragonian Well being Service Sector II in Zaragoza, Spain. The goals of the current report are: (1) to find out the purpose prevalence of T2D and medical despair comorbidity and therapy nonadherence; (2) to check if HbA1c and LDL-C, as major DM outcomes, are associated to TA on this inhabitants; and (3) to check if these DM major outcomes are related to TA independently of shared danger components for DM and despair, and sufferers’ well being behaviours.
A inhabitants of seven,271 sufferers with type-2 diabetes and comorbid medical despair was investigated for inclusion. People with confirmed diagnoses and drug therapy for each diseases (n = 3340) have been included within the present part I. Some extent prevalence of 1.9% was discovered for the T2D-depression comorbidity. The prevalence of sufferers nonadherent to therapy for these ailments was 35.4%. Multivariate analyses confirmed that decrease diabetes length, elevated yearly PCS visits, HbA1c and LDL-C ranges have been independently associated to therapy nonadherence.
These findings knowledgeable the event of a telephonic monitoring platform for therapy of nonadherence for folks with diabetes and comorbid despair and additional trial, cost-effectiveness, and prognostic research (phases II and III).
Proliferative diabetic retinopathy in sufferers with sort 2 diabetes correlates with the presence of atherosclerosis heart problems
Background: Atherosclerosis heart problems (ASCVD) is the primary explanation for morbidity and mortality in sort 2 diabetes mellitus (T2DM). As most diabetic sufferers with ASCVD are asymptomatic, it’s most uncared for in medical observe.
For that reason, figuring out high-risk ASCVD inhabitants with intensified therapy is essential. Lately, the connection between diabetic retinopathy (DR) and ASCVD has brought about a lot educational concern, however the outcomes are inconsistent. Furthermore, whether or not all grades of DR improve the chance of ASCVD stays controversial. Most significantly, only a few information will be present in China.
Goal: Our goal is to debate whether or not all grades of DR improve the chance of ASCVD after adjustment for the standard cardiovascular danger components and to evaluate the unbiased contribution of DR to cardiovascular occasions in sufferers with T2DM, hoping to offer extra proof for early identification of ASCVD.
Analysis design and strategies: A complete of 425 T2DM sufferers with full bodily and biochemical information have been included within the examine. The grade of DR was assessed with two 45 coloration digital retinal photographs. Based mostly on the presence of historical past of ASCVD, 425 T2DM sufferers have been divided into 2 teams: ASCVD group and non-ASCVD group.
Outcomes: ASCVD sufferers have been older and had a considerably greater fasting plasma glucose (FPG) and glycated haemoglobin (HbA1c) and proportion of historical past of ASCVD. On the identical time, they have been extra prone to be females, and had decrease stage of alcohol and calculated glomerular filtration fee (eGFR) than non-ASCVD sufferers. Their development to develop DR with ASCVD was considerably greater than sufferers with non-ASCVD (χ2 = 5.805, P = 0.016).
DR was an unbiased statistical indicator of the presence of ASCVD [odds ratio (OR) (95% CI): 2.321 (1.152-4.678), P = 0.018]. Moreover, when DR was divided into non-proliferative retinopathy (NPDR) and proliferative retinopathy (PDR) based on its severity, solely PDR was considerably related to incident ASCVD [OR (95% CI): 8.333 (1.813-38.304), P = 0.006].
After adjusting for conventional ASCVD danger components, such an affiliation nonetheless existed [OR (95% CI): 7.466 (1.355-41.137), P = 0.021].
Conclusion: DR associates strongly with ASCVD within the Chinese language inhabitants with T2DM. With the growing severity of DR, the chance of ASCVD additionally will increase. After adjustment for conventional danger components, PDR remains to be an unbiased danger marker for ASCVD.
Description: The protein may be important in cardiac antiarrhythmia via the strong suppression of voltage-gated L-type Ca2+ currents. As regulator of voltage-dependent L-type calcium channel subunit alpha-1C trafficking to the cell membrane. Inhibits cardiac hypertrophy through the calmodulin-dependent kinase II (CaMKII) pathway and phosphorylation and activation of CAMK2D. Mostly expressed in the heart and muscle of type II diabetic humans. Also found in the skeletal muscle, lung and adipose tissue. Lesser amounts in placenta and kidney.
Description: The protein may be important in cardiac antiarrhythmia via the strong suppression of voltage-gated L-type Ca2+ currents. As regulator of voltage-dependent L-type calcium channel subunit alpha-1C trafficking to the cell membrane. Inhibits cardiac hypertrophy through the calmodulin-dependent kinase II (CaMKII) pathway and phosphorylation and activation of CAMK2D. Mostly expressed in the heart and muscle of type II diabetic humans. Also found in the skeletal muscle, lung and adipose tissue. Lesser amounts in placenta and kidney.
Description: The protein may be important in cardiac antiarrhythmia via the strong suppression of voltage-gated L-type Ca2+ currents. As regulator of voltage-dependent L-type calcium channel subunit alpha-1C trafficking to the cell membrane. Inhibits cardiac hypertrophy through the calmodulin-dependent kinase II (CaMKII) pathway and phosphorylation and activation of CAMK2D. Mostly expressed in the heart and muscle of type II diabetic humans. Also found in the skeletal muscle, lung and adipose tissue. Lesser amounts in placenta and kidney.
Description: The protein may be important in cardiac antiarrhythmia via the strong suppression of voltage-gated L-type Ca2+ currents. As regulator of voltage-dependent L-type calcium channel subunit alpha-1C trafficking to the cell membrane. Inhibits cardiac hypertrophy through the calmodulin-dependent kinase II (CaMKII) pathway and phosphorylation and activation of CAMK2D. Mostly expressed in the heart and muscle of type II diabetic humans. Also found in the skeletal muscle, lung and adipose tissue. Lesser amounts in placenta and kidney.
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human RRAD . This antibody is tested and proven to work in the following applications:
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human SMAD7 (aa36-50). This antibody is tested and proven to work in the following applications:
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human APEX1 / APE1 (aa36-52). This antibody is tested and proven to work in the following applications:
Sheep Anti Human Decorin (Aa36-49) Polyclonal Antibody
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human LSP1 (aa37-48). This antibody is tested and proven to work in the following applications:
Description: A polyclonal antibody against RRAD. Recognizes RRAD from Human. This antibody is Unconjugated. Tested in the following application: WB, IHC, IF, ELISA;WB:1/500-1/2000.IHC:1/100-1/300.IF:1/200-1/1000.ELISA:1/20000
Description: A polyclonal antibody against RRAD. Recognizes RRAD from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, IHC;ELISA:1:1000-1:5000, IHC:1:25-1:100
Description: A polyclonal antibody against RRAD. Recognizes RRAD from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, IHC;ELISA:1:2000-1:5000, IHC:1:50-1:200
Description: A polyclonal antibody against RRAD. Recognizes RRAD from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC, IF;WB:1:500-1:3000, IHC:1:50-1:100, IF:1:100-1:500
Description: A polyclonal antibody against RRAD. Recognizes RRAD from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC, IF;WB:1:500-1:3000, IHC:1:50-1:100, IF:1:100-1:500
Description: Boster Bio Anti-RAD RRAD Antibody (Catalog# A30715). Tested in WB, IHC-P, IF, ICC, ELISA applications. This antibody reacts with Human, Rat, Mouse.
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human KX / XK (aa409-425). This antibody is tested and proven to work in the following applications:
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human KX / XK (aa22-38). This antibody is tested and proven to work in the following applications:
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human VGF (aa454-503). This antibody is tested and proven to work in the following applications:
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human ST7 (aa846-859). This antibody is tested and proven to work in the following applications:
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human TFG (aa350-400). This antibody is tested and proven to work in the following applications:
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human SYK (aa313-339). This antibody is tested and proven to work in the following applications:
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human RAN (aa167-216). This antibody is tested and proven to work in the following applications:
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human JMY (aa931-980). This antibody is tested and proven to work in the following applications:
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human GAK (aa101-150). This antibody is tested and proven to work in the following applications:
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human LTK (aa800-864). This antibody is tested and proven to work in the following applications:
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human SP1 (aa421-470). This antibody is tested and proven to work in the following applications:
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human MOG (aa163-174). This antibody is tested and proven to work in the following applications:
Description: A polyclonal antibody raised in Goat that recognizes and binds to Human ITK (aa596-607). This antibody is tested and proven to work in the following applications:
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human SLK (aa1151-1200). This antibody is tested and proven to work in the following applications:
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human APC (aa2794-2843). This antibody is tested and proven to work in the following applications:
Description: A polyclonal antibody raised in Goat that recognizes and binds to Human DCC (aa1437-1447). This antibody is tested and proven to work in the following applications:
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human SRC (aa92-109). This antibody is tested and proven to work in the following applications:
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human LAT (aa70-120). This antibody is tested and proven to work in the following applications:
Description: A polyclonal antibody raised in Goat that recognizes and binds to Human ING1 (aa285-296). This antibody is tested and proven to work in the following applications:
Description: A polyclonal antibody raised in Goat that recognizes and binds to Human TAB2 (aa161-173). This antibody is tested and proven to work in the following applications:
Description: A polyclonal antibody raised in Goat that recognizes and binds to Human WBP1 (aa165-174). This antibody is tested and proven to work in the following applications:
Description: A polyclonal antibody raised in Goat that recognizes and binds to Human NPR3 (aa520-533). This antibody is tested and proven to work in the following applications:
Description: A polyclonal antibody raised in Goat that recognizes and binds to Human OAS2 (aa357-371). This antibody is tested and proven to work in the following applications:
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human CLPP (aa215-277). This antibody is tested and proven to work in the following applications:
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human DAB1 (aa187-236). This antibody is tested and proven to work in the following applications:
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human DAB1 (aa199-248). This antibody is tested and proven to work in the following applications:
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human DAB1 (aa201-250). This antibody is tested and proven to work in the following applications:
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human DLL1 (aa155-173). This antibody is tested and proven to work in the following applications:
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human LRAT (aa111-160). This antibody is tested and proven to work in the following applications:
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human SOX2 (aa100-150). This antibody is tested and proven to work in the following applications:
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human SOX9 (aa147-196). This antibody is tested and proven to work in the following applications:
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human SOX9 (aa225-275). This antibody is tested and proven to work in the following applications:
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human SOX9 (aa316-510). This antibody is tested and proven to work in the following applications:
Description: A polyclonal antibody raised in Goat that recognizes and binds to Human ZIC3 (aa178-189). This antibody is tested and proven to work in the following applications:
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human ADD1 (aa411-460). This antibody is tested and proven to work in the following applications:
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human ADD3 (aa431-480). This antibody is tested and proven to work in the following applications:
Description: A polyclonal antibody raised in Goat that recognizes and binds to Human ARF4 (aa137-150). This antibody is tested and proven to work in the following applications:
Description: A polyclonal antibody raised in Goat that recognizes and binds to Human CAPG (aa205-217). This antibody is tested and proven to work in the following applications:
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human GNAS (aa385-394). This antibody is tested and proven to work in the following applications:
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human NEK2 (aa287-299). This antibody is tested and proven to work in the following applications:
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human CBLC (aa444-458). This antibody is tested and proven to work in the following applications:
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human RYBP (aa215-228). This antibody is tested and proven to work in the following applications:
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human MMP7 (aa132-146). This antibody is tested and proven to work in the following applications:
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human RAI2 (aa516-530). This antibody is tested and proven to work in the following applications:
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human MTBP (aa122-139). This antibody is tested and proven to work in the following applications:
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human CDC6 (aa400-500). This antibody is tested and proven to work in the following applications:
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human MSH2 (aa550-600). This antibody is tested and proven to work in the following applications:
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human SMC4 (aa281-297). This antibody is tested and proven to work in the following applications:
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human BAFF (aa254-269). This antibody is tested and proven to work in the following applications:
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human TLR7 (aa706-728). This antibody is tested and proven to work in the following applications:
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human CD3E (aa156-168). This antibody is tested and proven to work in the following applications:
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human MMP3 (aa251-478). This antibody is tested and proven to work in the following applications:
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human SKP2 (aa221-425). This antibody is tested and proven to work in the following applications:
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human AKT3 (aa119-136). This antibody is tested and proven to work in the following applications:
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human TLR7 (aa465-483). This antibody is tested and proven to work in the following applications:
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human TLR7 (aa900-950). This antibody is tested and proven to work in the following applications:
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human TPX2 (aa301-350). This antibody is tested and proven to work in the following applications:
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human TLR5 (aa300-350). This antibody is tested and proven to work in the following applications:
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human TLR1 (aa400-450). This antibody is tested and proven to work in the following applications:
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human NOD1 (aa930-949). This antibody is tested and proven to work in the following applications:
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human PJA2 (aa141-190). This antibody is tested and proven to work in the following applications:
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human IRX3 (aa271-320). This antibody is tested and proven to work in the following applications:
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human EBI3 (aa120-170). This antibody is tested and proven to work in the following applications:
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human GAB2 (aa125-174). This antibody is tested and proven to work in the following applications:
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human MMP7 (aa218-267). This antibody is tested and proven to work in the following applications:
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human PAK1 (aa178-227). This antibody is tested and proven to work in the following applications:
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human PAK1 (aa165-214). This antibody is tested and proven to work in the following applications:
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human RAP2 (aa140-190). This antibody is tested and proven to work in the following applications:
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human DGKZ (aa601-650). This antibody is tested and proven to work in the following applications:
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human HARS (aa460-509). This antibody is tested and proven to work in the following applications:
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human DQX1 (aa551-600). This antibody is tested and proven to work in the following applications:
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human IRF3 (aa164-424). This antibody is tested and proven to work in the following applications:
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human BUB1 (aa769-818). This antibody is tested and proven to work in the following applications:
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human DCXR (aa182-244). This antibody is tested and proven to work in the following applications:
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human HSF1 (aa267-315). This antibody is tested and proven to work in the following applications:
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human HSF1 (aa270-319). This antibody is tested and proven to work in the following applications:
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human IRS1 (aa289-338). This antibody is tested and proven to work in the following applications:
Description: A polyclonal antibody raised in Goat that recognizes and binds to Human ETFB (aa152-165). This antibody is tested and proven to work in the following applications:
Description: A polyclonal antibody raised in Goat that recognizes and binds to Human G6PD (aa305-318). This antibody is tested and proven to work in the following applications:
Description: A polyclonal antibody raised in Goat that recognizes and binds to Human G6PD (aa308-320). This antibody is tested and proven to work in the following applications:
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human GCLC (aa295-313). This antibody is tested and proven to work in the following applications:
Description: A polyclonal antibody raised in Goat that recognizes and binds to Human GOT2 (aa295-306). This antibody is tested and proven to work in the following applications:
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human HEXB (aa481-530). This antibody is tested and proven to work in the following applications:
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human CHML (aa128-177). This antibody is tested and proven to work in the following applications:
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human CRY2 (aa579-593). This antibody is tested and proven to work in the following applications:
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human DAB1 (aa191-240). This antibody is tested and proven to work in the following applications:
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human NAB2 (aa261-310). This antibody is tested and proven to work in the following applications:
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human DOK6 (aa111-160). This antibody is tested and proven to work in the following applications:
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human PEX7 (aa204-253). This antibody is tested and proven to work in the following applications:
Description: A polyclonal antibody raised in Goat that recognizes and binds to Human PLK3 (aa320-333). This antibody is tested and proven to work in the following applications:
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human PLTP (aa470-490). This antibody is tested and proven to work in the following applications:
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human HAP1 (aa639-653). This antibody is tested and proven to work in the following applications:
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human RGS1 (aa118-167). This antibody is tested and proven to work in the following applications:
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human SNX2 (aa350-400). This antibody is tested and proven to work in the following applications:
Description: A polyclonal antibody raised in Goat that recognizes and binds to Human SNX4 (aa438-450). This antibody is tested and proven to work in the following applications:
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human TAP2 (aa689-703). This antibody is tested and proven to work in the following applications:
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human TLK1 (aa730-779). This antibody is tested and proven to work in the following applications:
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human GGA2 (aa249-265). This antibody is tested and proven to work in the following applications:
